On 26 July this year, the Company submitted an application to build a Research and Development Centre \u2013 a modern facility which will integrate i.a. innovative projects of the Company.\u00a0 The total cost of the investment amounts to approx. PLN 80 million.
\nThe construction of Research and Development Centre will be financed by the proceeds raised from the initial public offering of the Company\u2019s shares as well as from the Innovative Economy Programme. Research and Development Centre will be constructed in immediate proximity to the Company’s Medicinal Product Production and Packaging Plant in Kazu\u0144 Nowy [Zak\u0142ad Wytwarzania i Konfekcjonowania Produkt\u00f3w Leczniczych Sp\u00f3\u0142ki].
\nMaciej Wieczorek, PhD, President of the Board of Celon Pharma S.A.:\u00a0We pursue a strategy which assumes that development and commercialisation of innovative therapies will constitute a key element of our business activity in the following years.\u00a0We act in accordance with the adopted schedule. At the present moment, we submitted an application for the construction along with documentation, and we are completing an executive design. These assumptions allow for full streamlining and optimisation of the R&D processes of the company to be conducted at one location by 2019.The new Celon Pharma S.A. Research and Development Centre will be equipped with a number of specialised laboratories. It is anticipated that the Centre will employ about 150 scientists.<\/p>\n","protected":false},"excerpt":{"rendered":"